Skip to main content
Equibles

Apollon Wealth Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1764387 MOUNT PLEASANT, SC
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$4,154,023
+$1,194,040 QoQ
Shares Held
6,662
+73.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#415
of 1,329 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 34% Shared 0% None 66%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Apollon Wealth Management, LLC holds $51,440,082 across 23 Biotechnology names. REGN ranks #3 (8.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 63,910 $31,746,014
2 BMRN
Biomarin Pharmaceutical Inc
 137,661 $7,876,962
3 REGN
Regeneron Pharmaceuticals, Inc.
This page 		6,662 $4,154,023
4 RARE
Ultragenyx Pharmaceutical Inc.
 123,449 $4,121,962
5 PTCT
Ptc Therapeutics, Inc.
 6,595 $537,954
6 CRSP
CRISPR Therapeutics AG
 8,350 $455,409
7 MRNA
Moderna, Inc.
 5,260 $368,357
8 HURA
TuHURA Biosciences, Inc./NV
 156,519 $366,254

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,154,023 6,662
2026-03-31 $2,959,983 3,831
2025-12-31 $2,753,260 3,567
2025-09-30 $1,947,141 3,463
2025-06-30 $1,757,700 3,348
2025-03-31 $2,215,999 3,494
2024-12-31 $1,226,632 1,722
2024-09-30 $1,673,574 1,592
2024-06-30 $1,760,475 1,675
2024-03-31 $1,641,045 1,705
2023-12-31 $1,130,359 1,287
2023-09-30 $800,740 973
2023-06-30 $654,589 911
2023-03-31 $624,469 760
2022-12-31 $577,192 800
2022-09-30 $938,240 1,362
2022-06-30 $740,094 1,252
2022-03-31 $921,914 1,320
2021-12-31 $852,552 1,350
2021-09-30 $738,319 1,220
2021-06-30 $821,612 1,471
2021-03-31 $846,447 1,789
2020-06-30 $9,978 16